Functional Validation of Glycolytic Enzymes (HK2 / PKM2 / LDHA)
The Problem With "Knock Out the Enzyme, Measure Glycolysis"
The experiment looks decisive and is usually ambiguous, for three reasons that apply differently to each enzyme.
| Reason | How it appears | How to test it |
|---|---|---|
| Isoenzyme compensation | Flux unchanged after knockout | Measure paralog expression; double knockout |
| Non-catalytic function | Phenotype changes while flux does not | Catalytically dead rescue; localisation assay |
| Enzyme not controlling flux | Flux unchanged but substrate or product pools shift | Perturb substrate supply; measure control by titration |
Important distinction. A null result from a knockout supports two very different conclusions: that the enzyme is dispensable for the measured flux, or that the enzyme was not the step being measured. Titrating substrate supply distinguishes them: if flux rises with substrate in the knockout as in the control, the enzyme was not limiting.
Part 1 — HK2 (and the Hexokinase Family)
| Feature | Detail | Consequence for validation |
|---|---|---|
| Family | HK1, HK2, HK3, HK4 (glucokinase) with different tissue distribution | HK2 knockout in a line expressing HK1 may show little change |
| Mitochondrial association | HK2 binds VDAC at the outer membrane | Detachment changes both glycolysis and apoptosis sensitivity |
| Product | Glucose-6-phosphate | Feeds glycolysis, PPP and glycogen; a change redistributes among three routes |
| Regulation | Inhibited by G6P; induced by HIF1A and MYC | Expression change is not flux change |
What an HK2 knockout can establish. In a line where HK1 is low, HK2 loss reduces glucose-6-phosphate production, and if glucose uptake also falls, the knockout has changed the entry step. That is a statement about hexokinase capacity.
What it cannot establish. That glycolytic flux fell, unless flux is measured: G6P can be maintained by glycogenolysis, and glucose-6-phosphatase activity (where present) can recycle. In lines with HK1 compensation, the knockout may change only the proportion of hexokinase activity that is mitochondrial.
Design note. Report HK1, HK2 and HK3 protein levels alongside the knockout. The most common review question about an HK2 paper is whether the paralog was measured.
Part 2 — PKM2 (and the Splicing Question)
PKM2 is the most frequently over-interpreted glycolytic enzyme, because it has three separable properties.
| Property | What it means | How to test |
|---|---|---|
| Pyruvate kinase activity | Converts PEP to pyruvate, generating ATP | Enzymatic assay on lysate; lactate production |
| Isoform choice | PKM1 versus PKM2 from alternative splicing of PKM | Isoform-specific primers or antibodies |
| Non-catalytic functions | Nuclear localisation, transcriptional co-activation, protein interactions | Catalytically dead mutant; nuclear fraction |
Caveat on PKM2 "knockout" designs. Standard knockouts of PKM remove both isoforms, which is often lethal or selects for adaptation, and isoform-specific effects cannot be attributed. A PKM2-specific exon-skipping design, or an isoform-swap (PKM2 to PKM1), is more informative and is the design that supports a claim about the isoform rather than about the gene.
Caveat on the tetramer–dimer story. The idea that PKM2 exists in a low-activity dimer that favours biosynthesis is widely cited and condition-dependent. Demonstrating it requires measuring the oligomeric state in cells, not inferring it from a proliferation phenotype; the available methods (crosslinking, native PAGE, and specific probes) each have artefacts, and the intracellular state is debated.
Design note. If the claim involves a nuclear function, a catalytically inactive mutant that still localises to the nucleus is the key control. Phosphoenolpyruvate or serine supplementation tests whether the phenotype is explained by metabolite supply rather than by the protein.
Part 3 — LDHA (and the Redox Constraint)
LDHA converts pyruvate to lactate while regenerating NAD⁺. Its knockout is the cleanest test of the lactate route and the least clean test of "glycolysis".
| Readout | Expected after LDHA knockout | Interpretation |
|---|---|---|
| Lactate release | Falls markedly | The route was used |
| Glucose consumption | Often falls, sometimes rises | NAD⁺ regeneration is now limiting, or the cell adapts |
| OCR | Often rises | Pyruvate is diverted to mitochondria, if capacity allows |
| NAD⁺/NADH (bulk) | May be unchanged | Compartment-specific pools are averaged |
| Growth in hypoxia | Typically impaired | The route matters when oxidation is limited |
Important distinction. LDHA loss is a redox perturbation as much as a carbon perturbation. In cells with sufficient respiratory capacity and an active malate–aspartate or glycerol phosphate shuttle, pyruvate can be oxidised and NAD⁺ regenerated mitochondrially; in cells without that capacity, glycolysis arrests at GAPDH. The same knockout therefore produces different phenotypes for reasons that have nothing to do with lactate.
Design note. The informative companion experiment is a pyruvate or an NAD⁺ precursor rescue: if pyruvate restores growth without restoring lactate, the limitation was redox or carbon, not lactate itself.
Part 4 — The Rescue That Separates Catalysis From Scaffolding
For all three enzymes, the single most informative control is a rescue with a mutant that cannot catalyse but is otherwise intact.
| Rescue construct | Restores | Establishes |
|---|---|---|
| Wild-type cDNA | Flux and phenotype | The phenotype is due to the gene |
| Catalytically dead mutant | Localisation, interactions, protein level | The phenotype requires catalysis |
| Catalytically dead mutant that fails to localise | Neither | The localisation signal, not catalysis, was required |
| Isoform swap (for PKM) | Catalysis with the other isoform | The isoform-specific property matters |
Reporting expression level, localisation and stability of each rescue construct is part of the control, not an optional extra. A catalytically dead mutant that is poorly expressed will produce a "catalysis is required" conclusion for the wrong reason.
Part 5 — Three Levels of Evidence for an Enzyme Claim
| Level | Claim | Minimum evidence | What does not count |
|---|---|---|---|
| Expression | The enzyme is present or induced | Protein, with isoform resolution | mRNA alone |
| Flux | The enzyme step limits flux | Titration, or flux measurement before and after perturbation | Enzyme activity in lysate alone |
| Dependence | The step is required for a phenotype | Knockout plus rescue, under the relevant constraint | Growth correlation at one condition |
Enzyme activity measured in a lysate sits between the first two levels and is frequently reported as the second. A lysate assay measures capacity under optimal substrate, not flux in the cell; the two diverge whenever substrate supply or allostery differs.
Part 6 — Failures That Recur
- • Paralogs unmeasured in a knockout study of a multi-isoform enzyme.
- • PKM knockout reported as PKM2 knockout.
- • Nuclear function claimed from a knockout without a localisation-defective or catalytically dead control.
- • LDHA phenotype attributed to lactate when redox or pyruvate supply explains it.
- • Lysate activity reported as flux.
- • Rescue construct not characterised for expression, localisation and stability.
- • Single clone compared with parental at a different passage.
- • Proliferation not measured, although biosynthetic demand sets the flux.
Part 7 — Where This Article Connects
This article sits under the pillar's partition-versus-rate distinction: each enzyme knockout changes a step, and whether that changes flux depends on control, which is distributed. The switch-level knockouts (PDK, MPC) are covered separately, as are the Seahorse protocols and the HK2-persistence troubleshooting article, which is written for the specific case where glycolysis survives the knockout.
If you need enzyme-level validation with paralog profiling and catalytic-dead rescue controls, we can scope the design with you.
Contact EDITGENE to request a project consultation or quote.
Scientific scope and validation note
Isoenzyme expression, mitochondrial association and isoform splicing vary by cell type and species; the expected directions here describe common patterns, not universal ones.
A knockout that leaves flux unchanged does not establish that the enzyme is dispensable, and a knockout that changes flux does not establish that the flux change caused the phenotype.
Scientific interpretation and experimental design
- • Three reasons for no phenotype. Compensation, moonlighting, and non-limiting control.
- • Measure the paralogs. The commonest review objection.
- • PKM is not PKM2. Isoform-specific designs are required for isoform claims.
- • LDHA is a redox enzyme. Pyruvate rescue separates carbon from redox.
- • Catalytically dead rescue is the key control. Characterise it before interpreting it.
- • Lysate activity is capacity, not flux.
Selected references for further reading
- • Patra KC, et al. Hexokinase 2 is required for tumour initiation and maintenance. Cell Metabolism. 2013;18:698–711.
- • Israelsen WJ, et al. PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cells. Cell. 2013;155:397–409.
- • Dayton TL, et al. Germline loss of PKM2 promotes metabolic distress and hepatocellular carcinoma. Genes & Development. 2016;30:1020–1033.
- • Fantin VR, St-Pierre J, Leder P. Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell. 2006;9:425–434.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| PBRM1 Knockout A-549 Cell Line | EDJ0001-K01 | Human | 55193 | Details Get a Quote |
| YTHDC1 Knockout A-549 Cell Line | EDC07652 | Human | 91746 | Details Get a Quote |
| TP53 Knockout HCT 116 Cell Line | EDC07854 | Human | 7157 | Details Get a Quote |
| Sirt2 Knockout MH-S Cell Line | EDJ-KQ78173 | Mouse | 64383 | Details Get a Quote |
| TFE3 Knockout KGN Cell Line | EDJ-KQ48 | Human | 7030 | Details Get a Quote |
| Stub1 Knockout MB49 Cell Line | EDJ-KQ53 | Mouse | 56424 | Details Get a Quote |
| ARID1A Knockout SNK-6 Cell Line | EDJ-KQ64 | Human | 8289 | Details Get a Quote |
| Tet1 Knockout Kupffer Cell Line | EDJ-KQ88 | Mouse | 52463 | Details Get a Quote |
| NR1H3 Knockout HEK293T Cell Line | EDJ-KQ109 | Human | 10062 | Details Get a Quote |
| NR1H2 Knockout HEK293T Cell Line | EDJ-KQ110 | Human | 7376 | Details Get a Quote |
| RPS6KB2 Knockout HEK293 Cell Line | EDJ-KQ125 | Human | 6199 | Details Get a Quote |
| SMAD6 Knockout HEK293 Cell Line | EDJ-KQ126 | Human | 4091 | Details Get a Quote |
| JUN Knockout HEK293 Cell Line | EDJ-KQ176 | Human | 3725 | Details Get a Quote |
| JUN Knockout HEK293T Cell Line | EDJ-KQ184 | Human | 3725 | Details Get a Quote |
| ALKBH5 Knockout HEK293 Cell Line | EDJ-KQ186 | Human | 54890 | Details Get a Quote |
- 1
- 2
- ...
- Next Page »